Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria

Arch Virol. 2011 Sep;156(9):1603-6. doi: 10.1007/s00705-011-0997-9. Epub 2011 Apr 11.

Abstract

We compared paired plasma and dried blood spot (DBS) samples from 54 HIV-1-treated children living in Bangui, Central African Republic, for antiretroviral-resistance-associated mutations. All children displayed virological failure (HIV-1 RNA >3.70 log(10)copies/ml). Testing for resistance genotype was carried out in a reference laboratory in Paris, France. A successful test result was obtained in 54 (100%) plasmas and 25 DBSs (46%). Among the 732 resistance-associated mutations analyzed, 718 were identical, leading to a high concordance rate of 98.1%. Genotypic resistance tests on DBS samples were found to be highly feasible and accurate in a foreign reference laboratory, but with additional costs for shipping and decreased sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Blood Specimen Collection / methods
  • Central African Republic / epidemiology
  • Child
  • Drug Resistance, Viral / genetics*
  • Genotype*
  • HIV Infections / diagnosis
  • HIV Infections / epidemiology
  • HIV Infections / virology*
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • Humans
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • RNA, Viral